Kathy L. Miller

938 total citations
17 papers, 312 citations indexed

About

Kathy L. Miller is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kathy L. Miller has authored 17 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Kathy L. Miller's work include Virus-based gene therapy research (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and Animal Virus Infections Studies (3 papers). Kathy L. Miller is often cited by papers focused on Virus-based gene therapy research (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and Animal Virus Infections Studies (3 papers). Kathy L. Miller collaborates with scholars based in United States, France and India. Kathy L. Miller's co-authors include Harold H. Harrison, L. J. Saif, R. F. Cross, Linda J. Saif, Sandra Zurawski, Joseph H. Phillips, Holly Cherwinski, Craig A. Murphy, Shuli Zhang and Mehrdad Moshrefi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Kathy L. Miller

17 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy L. Miller United States 9 106 91 89 42 37 17 312
John A. Shelly United States 9 98 0.9× 74 0.8× 65 0.7× 10 0.2× 10 0.3× 12 419
Kazue Nakanaga Japan 5 51 0.5× 164 1.8× 108 1.2× 104 2.5× 8 0.2× 10 333
Fanhua Wei China 12 153 1.4× 173 1.9× 70 0.8× 25 0.6× 18 0.5× 19 426
Erwin Daniel Brenndörfer Sweden 13 151 1.4× 91 1.0× 41 0.5× 29 0.7× 6 0.2× 22 442
Charles Allen United States 13 108 1.0× 92 1.0× 74 0.8× 6 0.1× 11 0.3× 20 360
Nadine Honke Germany 14 286 2.7× 150 1.6× 72 0.8× 18 0.4× 26 0.7× 24 499
Kazuhisa Otake Japan 11 140 1.3× 196 2.2× 92 1.0× 18 0.4× 9 0.2× 12 597
Holly Legault United States 9 88 0.8× 92 1.0× 172 1.9× 36 0.9× 4 0.1× 11 334
Ana Ferreira Portugal 13 156 1.5× 192 2.1× 31 0.3× 30 0.7× 9 0.2× 27 393
Satabdi Nandi United States 12 122 1.2× 146 1.6× 108 1.2× 59 1.4× 6 0.2× 14 373

Countries citing papers authored by Kathy L. Miller

Since Specialization
Citations

This map shows the geographic impact of Kathy L. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy L. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy L. Miller more than expected).

Fields of papers citing papers by Kathy L. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy L. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy L. Miller. The network helps show where Kathy L. Miller may publish in the future.

Co-authorship network of co-authors of Kathy L. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy L. Miller. A scholar is included among the top collaborators of Kathy L. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy L. Miller. Kathy L. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jeselsohn, Rinath, Jingxin Fu, Reshma Mahtani, et al.. (2024). Abstract PS12-02: Exploration of ctDNA Dynamics in the PACE Trial: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for HR+/HER2- Metastatic Breast Cancer. Cancer Research. 84(9_Supplement). PS12–2. 1 indexed citations
2.
Bialucha, Carl Uli, Kathy L. Miller, Stuart W. Hicks, et al.. (2016). Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates. mAbs. 8(3). 513–523. 17 indexed citations
3.
Abrams, Tinya J., Xiaohong Niu, Millicent Embry, et al.. (2015). Abstract 1695: Development of a novel antibody-drug conjugate for the treatment of c-Kit expressing solid tumors and AML. Cancer Research. 75(15_Supplement). 1695–1695. 2 indexed citations
5.
Menezes, Daniel L., Tinya J. Abrams, Yan Tang, et al.. (2015). Abstract 1682: Development and activity of a novel antibody-drug conjugate for the treatment of P-cadherin expressing cancers. Cancer Research. 75(15_Supplement). 1682–1682. 8 indexed citations
6.
Ardelt-Gattinger, Elisabeth, et al.. (2009). AD – EVA-KJ: Interdisziplinäres Testsystem zur Diagnostik und Evaluation bei Adipositas und anderen durch Ess- und Bewegungsverhalten beieinflussbaren Krankheiten im Kindes- und Jugendalter. 157. 1 indexed citations
7.
Cherwinski, Holly, Craig A. Murphy, Mike Bigler, et al.. (2005). The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function. The Journal of Immunology. 174(3). 1348–1356. 95 indexed citations
9.
Harrison, Harold H., et al.. (1992). Quality Assurance and Reproducibility of High-Resolution Two-Dimensional Electrophoresis and Silver Staining in Polyacrylamide Gels. American Journal of Clinical Pathology. 97(1). 97–105. 8 indexed citations
10.
Harrison, Harold H., et al.. (1992). Multiple Serum Protein Abnormalities in Carbohydrate-Deficient Glycoprotein Syndrome: Pathognomonic Finding of Two-Dimensional Electrophoresis?. Clinical Chemistry. 38(7). 1390–1392. 47 indexed citations
11.
Harrison, Harold H., Carole Ober, Kathy L. Miller, & Sherman Elias. (1991). High‐resolution two‐dimensional electrophoretic survey of serum protein genetic types in Schmiedeleut Hutterites. American Journal of Human Biology. 3(6). 639–646. 1 indexed citations
12.
Harrison, Harold H., Kathy L. Miller, & P. F. Whitington. (1990). Improved detection, via ISO-DALT two-dimensional electrophoresis, of "low Z expressor" individuals with alpha 1-antitrypsin MZ phenotype. Clinical Chemistry. 36(10). 1850–1851. 2 indexed citations
13.
Saif, Linda J., et al.. (1988). Cell culture propagation of bovine coronavirus. Methods in Cell Science. 11(3). 139–145. 20 indexed citations
14.
Saif, Linda J., B I Rosen, Shien‐Young Kang, & Kathy L. Miller. (1988). Cell culture propagation of rotaviruses. Methods in Cell Science. 11(3). 147–156. 21 indexed citations
15.
Saif, L. J., et al.. (1988). Serial propagation of porcine group C rotavirus (pararotavirus) in a continuous cell line and characterization of the passaged virus. Journal of Clinical Microbiology. 26(7). 1277–1282. 54 indexed citations
16.
Miller, Kathy L., et al.. (1982). Influence of asbestos fibers on collagen and prostaglandin production in fibroblast and macrophage co-cultures.. PubMed. 100(5). 778–85. 19 indexed citations
17.
Miller, Kathy L.. (1980). The in vivo effects of glass fibres on alveolar macrophage membrane characteristics.. PubMed. 459–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026